Brainsway Ltd (BWAY)

Currency in USD
21.78
+0.85(+4.06%)
Closed·
21.780.00(0.00%)
·
BWAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.9621.95
52 wk Range
7.8425.65
Key Statistics
Prev. Close
20.93
Open
21.29
Day's Range
20.96-21.95
52 wk Range
7.84-25.65
Volume
32.02K
Average Volume (3m)
91.49K
1-Year Change
112.2807%
Book Value / Share
1.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BWAY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
26.33
Upside
+20.91%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Brainsway Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Brainsway Ltd Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Compare BWAY to Peers and Sector

Metrics to compare
BWAY
Peers
Sector
Relationship
P/E Ratio
73.9x2.0x−0.5x
PEG Ratio
0.340.030.00
Price/Book
6.6x4.1x2.6x
Price / LTM Sales
9.4x3.9x3.3x
Upside (Analyst Target)
−0.4%43.5%45.8%
Fair Value Upside
Unlock10.1%6.4%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 26.33
(+20.91% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy30.00+37.74%24.00MaintainJan 26, 2026
H.C. Wainwright
Buy24.00+10.19%18.00MaintainDec 08, 2025
H.C. Wainwright
Buy18.00-17.36%17.00MaintainNov 14, 2025
H.C. Wainwright
Buy17.00-21.95%-MaintainAug 25, 2025
H.C. Wainwright
Buy17.00-21.95%16.00MaintainAug 14, 2025

Earnings

Latest Release
Nov 11, 2025
EPS / Forecast
0.04 / 0.05
Revenue / Forecast
13.50M / 13.06M
EPS Revisions
Last 90 days

BWAY Income Statement

People Also Watch

9.690
ONDS
+14.27%
12.3100
EOSE
+9.13%
41.830
IREN
+5.13%
3,329
BWAY
-0.66%
12.630
RCAT
+11.67%

FAQ

What Is the Brainsway (BWAY) Stock Price Today?

The Brainsway stock price today is 21.78

What Stock Exchange Does Brainsway Trade On?

Brainsway is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Brainsway?

The stock symbol for Brainsway is "BWAY."

What Is the Brainsway Market Cap?

As of today, Brainsway market cap is 418.42M.

What Is Brainsway's Earnings Per Share (TTM)?

The Brainsway EPS (TTM) is 0.13.

When Is the Next Brainsway Earnings Date?

Brainsway will release its next earnings report on Mar 10, 2026.

From a Technical Analysis Perspective, Is BWAY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Brainsway Stock Split?

Brainsway has split 0 times.

How Many Employees Does Brainsway Have?

Brainsway has 120 employees.

What is the current trading status of Brainsway (BWAY)?

As of Feb 07, 2026, Brainsway (BWAY) is trading at a price of 21.78, with a previous close of 20.93. The stock has fluctuated within a day range of 20.96 to 21.95, while its 52-week range spans from 7.84 to 25.65.

What Is Brainsway (BWAY) Price Target According to Analysts?

The average 12-month price target for Brainsway is USD26.33, with a high estimate of USD30 and a low estimate of USD19. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +20.91% Upside potential.

What Is the BWAY Premarket Price?

BWAY's last pre-market stock price is 21.92. The pre-market share volume is 200.00, and the stock has decreased by 0.99, or 4.73%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.